Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 25Peritoneal Neoplasms 17Fallopian Tube Neoplasms 11Colorectal Neoplasms 8Stomach Neoplasms 6Carcinoma, Ovarian Epithelial 6Neoplasms 3Hyperthermia 3Gastrointestinal Neoplasms 3Colonic Neoplasms 3Appendiceal Neoplasms 3Adrenocortical Carcinoma 3Sarcoma 2Rhabdomyosarcoma 2Recurrence 2Mesothelioma, Malignant 2Mesothelioma 2Glioma 2Glioblastoma 2Desmoplastic Small Round Cell Tumor 2Carcinoma 2Brain Neoplasms 2Adenoma, Islet Cell 2Wilms Tumor 1Retroperitoneal Neoplasms 1Rectal Neoplasms 1Pseudomyxoma Peritonei 1Postoperative Complications 1Pleural Effusion, Malignant 1Peritoneal Cavity Cancer 1

Interventions

Gastrectomy 4apatinib 3Taxes 3S 1 (combination) 3Oxaliplatin 3Cisplatin 3sintilimab 2Paclitaxel 2Hyperthermic Intraperitoneal Chemotherapy 2Drug Therapy 2Docetaxel 2Albumin-Bound Paclitaxel 2trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1tipiracil 1taxane 1pembrolizumab 1durvalumab 1disitamab vedotin 1cabozantinib 1andecaliximab 1XELOX 1Trifluridine 1Tegafur 1Tadalafil 1SHR-1701 1Resistance Training 1Radiotherapy 1Platinum 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastric Adenocarcinoma × Cytoreduction Surgical Procedures × Clear all
NCT07178808 2026-05-01

PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER

Banner Health

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡